{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T05:17:51Z","timestamp":1785561471734,"version":"3.56.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0200365","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T14:03:43Z","timestamp":1531317823000},"page":"e0200365","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":58,"title":["Biomarkers and predictors for functional and anatomic outcomes for small gauge pars plana vitrectomy and peeling of the internal limiting membrane in na\u00efve diabetic macular edema: The VITAL Study"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2257-9108","authenticated-orcid":true,"given":"Matias","family":"Iglicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Lavaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Ozimek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermino Pablo","family":"Negri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mali","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Loewenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinah","family":"Zur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"L Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract. Ireland"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archopht.122.4.552","article-title":"The prevalence of diabetic retinopathy among adults in the United States","volume":"122","author":"JH Kempen","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"JWY Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"Ranibizumab for diabetic macular edema: Results from 2 phase iii randomized trials: RISE and RIDE","volume":"119","author":"QD Nguyen","year":"2012","journal-title":"Ophthalmology"},{"key":"ref5","first-page":"615","article-title":"The RESTORE study: Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema","volume":"118","author":"P Mitchell","year":"2011","journal-title":"Ophthalmology. Elsevier Inc."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2337\/dc10-0493","article-title":"Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study","volume":"33","author":"P Massin","year":"2010","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.ophtha.2016.07.032","article-title":"Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies","volume":"123","author":"JS Heier","year":"2016","journal-title":"Ophthalmology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2147\/OPTH.S100168","article-title":"Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion","volume":"10","author":"S Sivaprasad","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/00325481.2014.994468","article-title":"United States comparative costs and absenteeism of diabetic ophthalmic conditions","volume":"127","author":"RA Brook","year":"2015","journal-title":"Postgrad Med. England"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bjophthalmol-2016-309313","article-title":"The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema","volume":"101","author":"C Egan","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2147\/OPTH.S128509","article-title":"Anti-VEGF treatment of diabetic macular edema in clinical practice: Effectiveness and patterns of use (ECHO study report 1)","volume":"11","author":"KJ Blinder","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1167\/iovs.12-11258","article-title":"Measuring the Effect of Pars Plana Vitrectomy on Vitreous Oxygenation Using Magnetic Resonance Imaging","volume":"43","author":"ARH Simpson","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref13","first-page":"307","article-title":"Increased retinal oxygen supply following pan-retinal photocoagulation and vitrectomy and lensectomy","volume":"79","author":"E Stefansson","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00006982-198200230-00006","article-title":"Vitrectomy, lensectomy, and ocular oxygenation","volume":"2","author":"E Stefansson","year":"1982","journal-title":"Retina. United States"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1167\/iovs.09-3582","article-title":"Vitreous VEGF clearance is increased after vitrectomy","volume":"51","author":"SS Lee","year":"2010","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"ref16","first-page":"2139","article-title":"Foveal Microstructure Analysis in Eyes with Diabetic Macular Edema Treated with Vitrectomy","volume":"34","author":"J Kogo","year":"2017","journal-title":"Adv Ther. Springer Healthcare"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2147\/OPTH.S104906","article-title":"Vitrectomy for center-involved diabetic macular edema","volume":"10","author":"DJ Browning","year":"2016","journal-title":"Clin Ophthalmol. New Zealand"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/112067210401400209","article-title":"Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal","volume":"14","author":"M Stefaniotou","year":"2004","journal-title":"Eur J Ophthalmol. United States"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00006982-200002000-00004","article-title":"Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane","volume":"20","author":"A Gandorfer","year":"2000","journal-title":"Retina. United States"},{"key":"ref20","article-title":"Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study","author":"R Adelman","year":"2015","journal-title":"BioMed Research International"},{"key":"ref21","first-page":"1","article-title":"Vitrectomy in the management of diabetic macular edema in treatment-na\u00efve patients","author":"Z Michalewska","year":"2017","journal-title":"Can J Ophthalmol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/IAE.0000000000000076","article-title":"Macular hypotrophy after internal limiting membrane removal for diabetic macular edema","volume":"34","author":"MR Romano","year":"2014","journal-title":"Retina"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1167\/iovs.12-10907","article-title":"Macular migration toward the optic disc after inner limiting membrane peeling for diabetic macular edema","volume":"54","author":"M Yoshikawa","year":"2013","journal-title":"Invest Ophthalmol Vis Sci. United States"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/sj.eye.6701945","article-title":"Pars plana vitrectomy for diabetic macular oedema: OCT and functional correlations","volume":"20","author":"JI Patel","year":"2006","journal-title":"Eye"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/IAE.0000000000001519","article-title":"Influence of Vitrectomy Surgery on the Integrity of Outer Retinal Layers in Diabetic Macular Edema","volume":"38","author":"A Uji","year":"2018","journal-title":"Retina"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00417-012-1968-x","article-title":"External limiting membrane as a predictor of visual improvement in diabetic macular edema after pars plana vitrectomy","volume":"250","author":"JK Chhablani","year":"2012","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"ref27","first-page":"1087","article-title":"Vitrectomy Outcomes in Eyes with Diabetic Macular Edema and Vitreomacular Traction","volume":"117","year":"2011","journal-title":"Ophthalmology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2008.10.001","article-title":"Diabetic macular edema: pathogenesis and treatment","volume":"54","author":"N Bhagat","year":"2009","journal-title":"Surv Ophthalmol. United States"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1034\/j.1600-0420.2001.790502.x","article-title":"The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology","volume":"79","author":"E Stefansson","year":"2001","journal-title":"Acta Ophthalmol Scand. Denmark"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00417-015-3251-4","article-title":"The effectiveness of vitrectomy for diffuse diabetic macular edema may depend on its preoperative optical coherence tomography pattern","volume":"254","author":"Y Ichiyama","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol. Germany"},{"key":"ref31","article-title":"Optical Coherence Tomography Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant","author":"D Zur","year":"2017","journal-title":"Ophthalmology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ophtha.2015.02.036","article-title":"Predictors of Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Ranibizumab","volume":"122","author":"R Sophie","year":"2015","journal-title":"Ophthalmology"},{"key":"ref33","article-title":"Predictive Value of Optical Coherence Tomographic Features in the Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME) Study","author":"W Fickweiler","journal-title":"Retina. United States"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/IAE.0b013e31826b6763","article-title":"Visual outcome after intravitreal bevacizumab depends on the optical coherence tomographic patterns of patients with diffuse diabetic macular edema","volume":"33","author":"M Shimura","year":"2013","journal-title":"Retina"},{"key":"ref35","first-page":"797","article-title":"Functional and Anatomical Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab","author":"A Giocanti-Auregan","year":"2017","journal-title":"Functional and Anatomical Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab"},{"key":"ref36","first-page":"588","article-title":"Visual and Morphologic Outcomes of Intravitreal Ranibizumab for Diabetic Macular Edema Based on Optical Coherence Tomography Patterns","volume":"36","author":"KH Seo","year":"2016","journal-title":"Retina. United States"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archophthalmol.2012.1107","article-title":"Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab","volume":"130","author":"SB Bressler","year":"2012","journal-title":"Arch Ophthalmol. United States"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1111\/aos.12925","article-title":"The occurrence of delayed ocular hypertension and glaucoma after pars plana vitrectomy for rhegmatogenous retinal detachment","author":"D Ivastinovic","year":"2016","journal-title":"Acta ophthalmologica. England"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ajo.2006.02.014","article-title":"LXII Edward Jackson lecture: open angle glaucoma after vitrectomy","volume":"141","author":"S Chang","year":"2006","journal-title":"Am J Ophthalmol. United States"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1167\/iovs.10-5666","article-title":"Oxygen distribution in the human eye: relevance to the etiology of open-angle glaucoma after vitrectomy","volume":"51","author":"CJ Siegfried","year":"2010","journal-title":"Invest Ophthalmol Vis Sci. United States"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0200365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T14:55:05Z","timestamp":1540220105000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0200365"}},"subtitle":[],"editor":[{"given":"Andreas","family":"Wedrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0200365","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,11]]}}}